BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11172339)

  • 1. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
    Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
    Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of liver cirrhosis in rats by curcumin.
    Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
    Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
    Nagler A; Gofrit O; Ohana M; Pode D; Genina O; Pines M
    J Urol; 2000 Nov; 164(5):1776-80. PubMed ID: 11025768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
    Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
    Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
    Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O; Patsenker E; Lis R; Buko VU
    Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone.
    Gnainsky Y; Spira G; Paizi M; Bruck R; Nagler A; Genina O; Taub R; Halevy O; Pines M
    Cell Tissue Res; 2006 Jun; 324(3):385-94. PubMed ID: 16508789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats.
    Parsons CJ; Bradford BU; Pan CQ; Cheung E; Schauer M; Knorr A; Krebs B; Kraft S; Zahn S; Brocks B; Feirt N; Mei B; Cho MS; Ramamoorthi R; Roldan G; Ng P; Lum P; Hirth-Dietrich C; Tomkinson A; Brenner DA
    Hepatology; 2004 Nov; 40(5):1106-15. PubMed ID: 15389776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofuginone, an inhibitor of collagen synthesis by rat stellate cells, stimulates insulin-like growth factor binding protein-1 synthesis by hepatocytes.
    Gnainsky Y; Spira G; Paizi M; Bruck R; Nagler A; Abu-Amara SN; Geiger B; Genina O; Monsonego-Ornan E; Pines M
    J Hepatol; 2004 Feb; 40(2):269-77. PubMed ID: 14739098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.
    Gnainsky Y; Kushnirsky Z; Bilu G; Hagai Y; Genina O; Volpin H; Bruck R; Spira G; Nagler A; Kawada N; Yoshizato K; Reinhardt DP; Libermann TA; Pines M
    Cell Tissue Res; 2007 Apr; 328(1):153-66. PubMed ID: 17180598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
    Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
    Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis.
    Bruck R; Schey R; Aeed H; Hochman A; Genina O; Pines M
    Liver Int; 2004 Apr; 24(2):169-76. PubMed ID: 15078482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats.
    Weng TC; Shen CC; Chiu YT; Lin YL; Huang YT
    Phytother Res; 2012 Mar; 26(3):344-53. PubMed ID: 21717514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats.
    Spira G; Mawasi N; Paizi M; Anbinder N; Genina O; Alexiev R; Pines M
    J Hepatol; 2002 Sep; 37(3):331-9. PubMed ID: 12175628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
    Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.
    Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H
    Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced hypothyroidism accelerates the regression of liver fibrosis in rats.
    Bruck R; Weiss S; Traister A; Zvibel I; Aeed H; Halpern Z; Oren R
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2189-94. PubMed ID: 18031379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
    Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation.
    Wang CH; Lee TH; Lu CN; Chou WY; Hung KS; Concejero AM; Jawan B
    Gene Ther; 2006 Jul; 13(13):1000-9. PubMed ID: 16511523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.
    Elkin M; Ariel I; Miao HQ; Nagler A; Pines M; de-Groot N; Hochberg A; Vlodavsky I
    Cancer Res; 1999 Aug; 59(16):4111-8. PubMed ID: 10463616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.